Clinical Trials in Beijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 2
GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.
Colorectal, Cancer
Chinese PLA General Hospital120 enrolled1 locationNCT06558773
Recruiting
Phase 1Phase 2
BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL
Acute Lymphocytic Leukemia
Chinese PLA General Hospital30 enrolled2 locationsNCT07008885
Recruiting
Phase 1
PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
Hepatocellular CarcinomaAdult
Chinese PLA General Hospital25 enrolled1 locationNCT07018518
Recruiting
Phase 1Phase 2
CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma
Lymphoma
Chinese PLA General Hospital30 enrolled1 locationNCT05948033